BackApexigen Overview

Apexigen Total Current Liabilities

Track Apexigen's total current liabilities ($15M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$15.40M
99.68% YoYΔ $-4.80B vs prior year quarter

Peer average

Loading

Apexigen Total Current Liabilities History

Loading

Apexigen vs. peers: Total Current Liabilities Comparison

Loading

Apexigen Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Apexigen (APGN) FAQ

Apexigen posts a total current liabilities of $15M as of June 2023. That compares with $4.8B in the prior-year period — down 99.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Apexigen's total current liabilities was $4.8B. The latest reading is $15M — a 99.7% year-over-year decrease (period ending June 2023). Use the history and growth charts on this page for a longer lookback.

Total Current Liabilities is one piece of Apexigen's financial statement story. At $15M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for APGN's total current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Apexigen's other metric pages and overview cover the third.